BPG is committed to discovery and dissemination of knowledge
Homepage
Online Submission
Number of total visits
2400540
Number of visits today
555
Number of downloads
1572978
MEMBERSHIP
Cited by in F6Publishing
Number
Citing Articles
1
Kalva SP , Pectasides M, Yeddula K, Ganguli S, Blaszkowsky LS, Zhu AX. Factors Affecting Survival following Chemoembolization with Doxorubicin-eluting Microspheres for Inoperable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2013;24 :257-65. [DOI: 10.1016/j.jvir.2012.10.021 ] [ Cited by in Crossref: 7] [ Cited by in F6Publishing: 6 ] [ Article Influence: 0.8 ] [ Reference Citation Analysis ]
2
Zhang ZM , Guo JX , Zhang ZC , Jiang N , Zhang ZY , Pan LJ . Therapeutic options for intermediate-advanced hepatocellular carcinoma. World J Gastroenterol 2011;17 :1685-9. [PMID: 21483627 DOI: 10.3748/wjg.v17.i13.1685 ] [ Cited by in CrossRef: 25 ] [ Cited by in F6Publishing: 29 ] [ Article Influence: 2.3 ] [ Reference Citation Analysis ]
3
Mahady SE , Wong G , Craig JC , George J . Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis. Hepatology 2012;56 :2172-9. [PMID: 22707355 DOI: 10.1002/hep.25887 ] [ Cited by in Crossref: 27] [ Cited by in F6Publishing: 26 ] [ Article Influence: 3.0 ] [ Reference Citation Analysis ]
4
Pritchard-Jones J , Stevens C , McCaughan G , Strasser S . Feasibility, acceptability and safety of a nurse led hepatitis B clinic based in the community. Collegian 2015;22 :233-40. [PMID: 26281412 DOI: 10.1016/j.colegn.2015.03.002 ] [ Cited by in Crossref: 1] [ Cited by in F6Publishing: 1 ] [ Article Influence: 0.1 ] [ Reference Citation Analysis ]
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345